| Name | Mutant IDH1-IN-2 |
|---|---|
| Synonyms |
(S)-3-(2-(((S)-1-(4-((4,4-Difluoropiperidin-1-yl)methyl)phenyl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
(4S)-3-(2-{[(1S)-1-{4-[(4,4-Difluoro-1-piperidinyl)methyl]phenyl}ethyl]amino}-4-pyrimidinyl)-4-isopropyl-1,3-oxazolidin-2-one inhibit,Mutant IDH1 IN 2,Inhibitor,Mutant IDH-1-IN-2,Mutant IDH1IN2,Isocitrate Dehydrogenase (IDH) 2-Oxazolidinone, 3-[2-[[(1S)-1-[4-[(4,4-difluoro-1-piperidinyl)methyl]phenyl]ethyl]amino]-4-pyrimidinyl]-4-(1-methylethyl)-, (4S) AG-881,Mutant IDH1-IN-2 Mutant IDH1-IN-2, 10 mM in DMSO Mutant IDH1 inhibitor 2 |
| Description | Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS-MS biochemical assay, IC50 of 16.6 nM in Fluorescence biochemical assay.Target: Mutant IDH1Mutant IDH1-IN-2 has a neomorphic activity and in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer. More bioactivity information in Patent WO 2013046136A1 (Example 224). |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 578.1±60.0 °C at 760 mmHg |
| Molecular Formula | C24H31F2N5O2 |
| Molecular Weight | 459.532 |
| Flash Point | 303.4±32.9 °C |
| Exact Mass | 459.244568 |
| LogP | 2.72 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.587 |
| Storage condition | 2-8℃ |